C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 453/02 (2006.01) A61K 31/439 (2006.01) A61P 11/00 (2006.01)
Patent
CA 2733449
The invention provides (R)-1-[3-(R)-cyclohexyl-hydroxy-phenyl-methyl)-isoxazol-5-ylmethyl]-3-(3- fluorophenoxy)-1-azonia-bicyclo[2.2.2]octane 2-hydroxyeth anesulf onate, pharmaceutical compositions containing the compound and its use as a muscarinic antagonists, for the treatment of chronic obstructive pulmonary disease.
Linvention concerne le 2-hydroxy-éthanesulfonate de (R)-1-[3-(R)-cyclohexyl-hydroxy-phényl-méthyl)-isoxazol-5-ylméthyl]-3- (3-fluoro-phénoxy)-1-azonia-bicyclo[2.2.2]octane, des compositions pharmaceutiques renfermant le composé et son utilisation en tant quantagoniste muscarinique, pour le traitement de la bronchopneumopathie chronique obstructive.
Astrazeneca Ab
Fetherstonhaugh & Co.
Pulmagen Therapeutics (synergy) Limited
LandOfFree
2-hydroxy-ethanesulfonate salt does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-hydroxy-ethanesulfonate salt, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-hydroxy-ethanesulfonate salt will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1709525